PDF
ePub
Citation
Print
Abstract
Purpose
We examined aqueous humor levels of 25-hydroxyvitamin D (vitamin D) in patients with age-related macular degeneration to investigate possible relationships between aqueous humor vitamin D levels and clinical manifestations.
Methods
Patients > 50 years of age, 52 eyes of 34 patients with age-related macular degeneration, and 23 eyes of 17 patients treated with cataract surgery without retinal disease, were examined for aqueous humor vitamin D levels and compared. The experimental group was divided into two groups according to the median value of aqueous humor vitamin D levels. We compared the clinical manifestations of macular degeneration in both groups and identified relationships between aqueous humor vitamin D levels and clinical features.
Results
Vitamin D levels in the aqueous humor were significantly lower in the experimental group than in the control group (experimental, 10.03 ± 10.1 ng/mL vs. control group, 40.8 ± 16.4 ng/mL; p < 0.001). Patients with high vitamin D levels in the macular degeneration group had a higher percentage of fibrovascular pigment epithelial detachments than those in the low grade group (high grade group, 65% vs. low grade group, 27%; p = 0.003). Multiple linear regression analysis showed a significant correlation between vitamin D levels and the total number of anti-vascular endothelial growth factor intravitreal injections within 6 months (standardize coefficient, β = −0.336).
Conclusions
Patients with wet age-related macular degeneration had significantly lower vitamin D levels in the aqueous humor compared to control group subjects of similar ages. However, in patients with macular degeneration, low vitamin D levels were associated with a greater number of intravitreal injections, while higher levels of vitamin D may lead to more advanced forms of fibrovascular retinal pigment epithelium and related low vision. These relationships were not always constant, so further studies on the relationships between local vitamin D levels and ocular disorders are needed.
Figures and Tables
Table 1
Patients demographics and the aqueous humor 25-hydroxyvitamin D level between control and age-related macular degeneration patients
Notes
References
1. Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010; 9:941–955.
2. Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013; 5:2502–2521.
3. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008; 29:726–776.
4. Alsalem JA, Patel D, Susarla R, et al. Characterization of vitamin D production by human ocular barrier cells. Invest Ophthalmol Vis Sci. 2014; 55:2140–2147.
5. Johnson JA, Grande JP, Roche PC, et al. Immuno-localization of the calcitriol receptor, calbindin-d28k and the plasma membrane calcium pump in the human eye. Curr Eye Res. 1995; 14:101–108.
6. Verstappen A, Parmentier M, Chirnoaga M, et al. Vitamin D-dependent calcium binding protein immunoreactivity in human retina. Ophthalmic Res. 1986; 18:209–214.
7. Jones G, Prosser DE, Kaufmann M. Cytochrome p450-mediated metabolism of vitamin D. J Lipid Res. 2014; 55:13–31.
8. Lin Y, Ubels JL, Schotanus MP, et al. Enhancement of vitamin D metabolites in the eye following vitamin D3 supplementation and uv-b irradiation. Curr Eye Res. 2012; 37:871–878.
9. Millen AE, Meyers KJ, Liu Z, et al. Association between vitamin D status and age-related macular degeneration by genetic risk. JAMA Ophthalmol. 2015; 133:1171–1179.
10. Kawasaki R, Yasuda M, Song SJ, et al. The prevalence of age-related macular degeneration in asians: a systematic review and meta-analysis. Ophthalmology. 2010; 117:921–927.
11. Velez-Montoya R, Oliver SC, Olson JL, et al. Current knowledge and trends in age-related macular degeneration: Genetics, epidemiology, and prevention. Retina. 2014; 34:423–441.
12. Parekh N, Chappell RJ, Millen AE, et al. Association between vitamin D and age-related macular degeneration in the third national health and nutrition examination survey, 1988 through 1994. Arch Ophthalmol. 2007; 125:661–669.
13. Lee WJ, Kang MH, Seong M, Cho HY. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion. Br J Ophthalmol. 2012; 96:1426–1430.
14. Kutuzova GD, Gabelt BT, Kiland JA, et al. 1α, 25-Dihydroxyvitamin D (3) and its analog, 2-methylene-19-nor-(20S)-1α, 25-dihydroxyvitamin D (3) (2MD), suppress intraocular pressure in non-human primates. Arch Biochem Biophys. 2012; 518:53–60.
15. Kim EC, Han K, Jee D. Inverse relationship between high blood 25-hydroxyvitamin D and late stage of age-related macular degeneration in a representative korean population. Invest Ophthalmol Vis Sci. 2014; 55:4823–4831.
16. Itty S, Day S, Lyles KW, et al. Vitamin D deficiency in neovascular versus nonneovascular age-related macular degeneration. Retina. 2014; 34:1779–1786.
17. Singh A, Falk MK, Subhi Y, Sørensen TL. The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study. PLoS One. 2013; 8:e70948.
18. Golan S, Shalev V, Treister G, et al. Reconsidering the connection between vitamin D levels and age-related macular degeneration. Eye (Lond). 2011; 25:1122–1129.
19. Annweiler C, Drouet M, Duval GT, et al. Circulating vitamin D concentration and age-related macular degeneration: systematic review and meta-analysis. Maturitas. 2016; 88:101–112.
20. Wu W, Weng Y, Guo X, et al. The association between serum vitamin D levels and age-related macular degeneration: a systematic meta-analytic review. Invest Ophthalmol Vis Sci. 2016; 57:2168–2177.
21. Cougnard-Gregoire A, Merle BM, Korobelnik JF, et al. Vitamin D deficiency in community-dwelling elderly is not associated with age-related macular degeneration. J Nutr. 2015; 145:1865–1872.
22. Brown CJ, Akaichi F. Vitamin D deficiency and posterior subcapsular cataract. Clin Ophthalmol. 2015; 9:1093–1098.
XML Download